Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'WARFARIN-FLUCONAZOLE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 13 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wienkers, LC
      Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    2. Niemi, M; Backman, JT; Neuvonen, M; Laitila, J; Neuvonen, PJ; Kivisto, KT
      Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    3. Schrag, ML; Wienkers, LC
      Covalent alteration of the CYP3A4 active site: Evidence for multiple substrate binding domains

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    4. Kantola, T; Backman, JT; Niemi, M; Kivisto, KT; Neuvonen, PJ
      Effect of fluconazole on plasma fluvastatin and pravastatin concentrations

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    5. Benedetti, MS; Bani, M
      Metabolism-based drug interactions involving oral azole antifungals in humans

      DRUG METABOLISM REVIEWS
    6. Hassan, M; Svensson, USH; Ljungman, P; Bjorkstrand, B; Olsson, H; Bielenstein, M; Abdel-Rehim, M; Nilsson, C; Johansson, M; Karlsson, MO
      A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    7. Davit, B; Reynolds, K; Yuan, R; Ajayi, F; Conner, D; Fadiran, E; Gillespie, B; Sahajwalla, C; Huang, SM; Lesko, LJ
      FDA evaluations using in vitro metabolism to predict and interpret in vivometabolic drug-drug interactions: Impact on labeling

      JOURNAL OF CLINICAL PHARMACOLOGY
    8. McKillop, D; Back, DJ; McCormick, AD; Evans, JA; Tjia, J
      Preclinical and in vitro assessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions

      XENOBIOTICA
    9. Tiboni, GM; Iammarrone, E; Giampietro, F; Lamonaca, D; Bellati, U; Di Ilio, C
      Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin

      TERATOLOGY
    10. BECQUEMONT L; LEBOT MA; RICHE C; FUNCKBRENTANO C; JAILLON P; BEAUNE P
      USE OF HETEROLOGOUSLY EXPRESSED HUMAN CYTOCHROME-P450 1A2 TO PREDICT TACRINE-FLUVOXAMINE DRUG-INTERACTION IN MAN

      Pharmacogenetics
    11. Lambiotte, F; Chagnon, JL; Socolovsky, C
      Difficulty in regulating coagulation when using a fluconazole-fluindione combination: A report on two cases

      MEDECINE ET MALADIES INFECTIEUSES
    12. MINERS JO; BIRKETT DJ
      CYTOCHROME P4502C9 - AN ENZYME OF MAJOR IMPORTANCE IN HUMAN DRUG-METABOLISM

      British journal of clinical pharmacology
    13. MICHALETS EL
      UPDATE - CLINICALLY SIGNIFICANT CYTOCHROME-P-450 DRUG-INTERACTIONS

      Pharmacotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 05:14:51